Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rachel M. Wolfe"'
Publikováno v:
BMC Rheumatology, Vol 7, Iss 1, Pp 1-6 (2023)
Abstract Background VEXAS is a recently described inflammatory disease caused by mutations in the UBA1 gene. Symptoms are diverse and include fevers, cartilaginous inflammation, lung inflammation, vasculitis, neutrophilic dermatoses, and macrocytic a
Externí odkaz:
https://doaj.org/article/812f200a8371437a9dad1592f236128d
Autor:
Marcy B. Bolster, Jason Kolfenbach, Alexandra Poeschla, Lisa Criscione‐Schreiber, Faye Hant, Rumey Ishizawar, Beth Jonas, David Leverenz, Kenneth S. O'Rourke, Rachel M. Wolfe, Lisa Zickuhr
Publikováno v:
Arthritis Care & Research.
Publikováno v:
Semin Arthritis Rheum
OBJECTIVE: No guidelines exist for Pneumocystis jirovecii pneumonia (PJP) prophylaxis in patients with systemic lupus erythematosus (SLE). Limited data are available on incidence of PJP infection and use of PJP prophylaxis. Using a real-world, electr
Autor:
Jessica Tate, Joshua Sheehan, Carol P. Geer, Amy K Guzik, Ryan T. Mott, Roy E. Strowd, Rachel M. Wolfe
Publikováno v:
Neurology. 90:808-811
ObjectiveTo highlight the importance of a broad differential and histopathologic confirmation in patients with newly diagnosed cancer with brain lesions atypical for CNS metastasis.MethodsWe report 2 cases of biopsy-proven CNS vasculitis in patients
Publikováno v:
Open Forum Infectious Diseases
Background Immunosuppressive therapy for connective tissue diseases (CTDs) increases risk for opportunistic infections including Pneumocystis pneumonia (PCP). High mortality rates are reported in CTD patients with PCP, which suggests a potential need
Autor:
Rachel M. Wolfe, James E. Peacock
Publikováno v:
Current rheumatology reports. 19(6)
Immunosuppressive therapy for connective tissue diseases (CTDs) is steadily becoming more intense. The resultant impairment in cell-mediated immunity has been accompanied by an increasing risk for opportunistic infection (OI). Pneumocystis pneumonia
Autor:
Rachel M. Wolfe, Dennis C. Ang
Publikováno v:
Immunology and allergy clinics of North America. 37(2)
Biologic therapy continues to revolutionize the treatment of autoimmune disease, especially in rheumatology as the pathophysiology of both inflammation and autoimmune disease becomes better understood. These therapies are designed to dampen the respo